Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 15;4(4):102576.
doi: 10.1016/j.xpro.2023.102576. Epub 2023 Sep 20.

Ultrasound-guided lymph node fine-needle aspiration for evaluating post-vaccination germinal center responses in humans

Affiliations

Ultrasound-guided lymph node fine-needle aspiration for evaluating post-vaccination germinal center responses in humans

Larissa L S Scholte et al. STAR Protoc. .

Abstract

The lymph node (LN) is a critical biological site for immune maturation after vaccination as it includes several cell populations critical for priming the antibody response. Here, we present a protocol for sampling the LN and isolating cell populations to evaluate immunogens targeting germline cells. We describe steps for media and tube preparation and sample collection using an ultrasound-guided LN fine-needle aspiration procedure. This protocol is safe, quick, low-cost, and less invasive than excisional biopsy. For complete details on the use and execution of this protocol, please refer to Leggat et al. (2022).1.

Keywords: Cell Isolation; Clinical Protocol; Immunology.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

Figures

None
Graphical abstract
Figure 1
Figure 1
Ultrasound-guided lymph node fine-needle aspiration (A) The ultrasound probe is positioned for optimal visualization over an enlarged axillary lymph node of the arm recently receiving an immunization of an investigational product (i.e., a “draining lymph node”). (B) Once puncture of the LN is visualized on US, negative pressure is applied to the syringe by withdrawing plunger to approximately the 2–3 mL mark on the syringe barrel using a gentle “to” and “fro” motion. (C) US image of a 23-gauge needle entering the cortex of an axillary lymph node. This procedure is repeated up to 4 times to gather a sufficient amount of sampling material.
Figure 2
Figure 2
50 mL conical tubes after FNA collection The tube containing the sample “For Collection” shows a darker reddish color than the tube containing media “For Flushing” only.
Figure 3
Figure 3
Workflow summarizing the LN-FNA pre-analytics, processing, and storage steps
Figure 4
Figure 4
US-LN-FNA cell pellet after centrifugation (A–D) Stages in processing the sample for GCC isolation.
Figure 5
Figure 5
US-LN-FNA sample images captured by the Cellometer Auto 2000 using the AOPI viability method (A and B) (A) shows a bright-field image within the expected cell concentration and highlights an area containing red blood cells (red arrow in the zoomed-inbox) that are not shown in the combined fluorescent panel (B) since only nucleated cells are counted using AOPI. (B) Shows combined fluorescent images with counted live cells circled in green and counted dead cells circled in red (highlighted in the zoomed-in box by an orange arrow).
Figure 6
Figure 6
Representative dataset showing the total live cell count and viability of sixty-two US-LN-FNA samples collected and processed following this protocol The y-axis shows a log10 transformation. The vast majority of samples show high viability (>80%) and a total live cell count >500,000 cells. Note: This figure shows the viability for fresh samples. US-LN-FNA aliquots properly cryopreserved and thawed following best practices should not result in viability decrease greater than 10% post-cryopreservation.

References

    1. Leggat D.J., Cohen K.W., Willis J.R., Fulp W.J., decamp A.C., Kalyuzhniy O., Cottrell C.A., Menis S., Finak G., Ballweber-Fleming L., et al. Vaccination induces HIV, broadly neutralizing antibody precursors in humans. Science. 2022;378 doi: 10.1126/science.add6502. - DOI - PMC - PubMed
    1. Havenar-Daughton C., Carnathan D.G., Torrents de la Peña A., Pauthner M., Briney B., Reiss S.M., Wood J.S., Kaushik K., van Gils M.J., Rosales S.L., et al. Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env Trimer. Cell Rep. 2016;17:2195–2209. doi: 10.1016/j.celrep.2016.10.085. - DOI - PMC - PubMed
    1. Patricia D'Souza M., Allen M.A., Baumblatt J.A.G., Boggiano C., Crotty S., Grady C., Havenar-Daughton C., Heit A., Hu D.J., Kunwar N., et al. Innovative approaches to track lymph node germinal center responses to evaluate development of broadly neutralizing antibodies in human HIV vaccine trials. Vaccine. 2018;36:5671–5677. doi: 10.1016/j.vaccine.2018.07.071. - DOI - PubMed
    1. Havenar-Daughton C., Newton I.G., Zare S.Y., Reiss S.M., Schwan B., Suh M.J., Hasteh F., Levi G., Crotty S. Normal human lymph node T follicular helper cells and erminal center B cells accessed via fine needle aspirations. J. Immunol. Methods. 2020;479 doi: 10.1016/j.jim.2020.112746. - DOI - PMC - PubMed
    1. Law H., Mach M., Howe A., Obeid S., Milner B., Carey C., Elfis M., Fsadni B., Ognenovska K., Phan T.G., et al. Early expansion of CD38+ICOS+ GC Tfh in draining lymph nodes during influenza vaccination immune response. iScience. 2022;25 doi: 10.1016/j.isci.2021.103656. - DOI - PMC - PubMed

Publication types

LinkOut - more resources